Evotec - About the company
Evotec is a public company based in Hamburg (Germany), founded in 1993. It operates as an AI-driven life science company accelerating drug discovery and development. Evotec has raised $25.1M in funding. The company has 6 active competitors, including 1 that has exited. Its top competitors include companies like Euretos, Mechanome Bio and CellCircuit.
Company Details
AI-driven life science company accelerating drug discovery and development. It is focused on pioneering drug discovery and preclinical development using advanced technologies, deep disease expertise, and integrated R&D platforms. It accelerates the creation of new therapies across modalities, including small molecules and biologics, to bring life-changing medicines to patients faster.
- Website
- www.evotec.com/
- Email ID
- *****@evotec.com
- Phone Number
- +49 **********
- Registered Address
- Essener Bogen 7, DE-22419 HAMBURG
Key Metrics
Founded Year
1993
Location
Hamburg, Germany
Stage
Public
Total Funding
$25.1M in 23 rounds
Latest Funding Round
Investors
Ranked
1st among 6 active competitors
Annual Revenue
€500M - €1B as on Dec 31, 2024
Employee Count
4,693 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Evotec
Evotec is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Evotec SE CIN: K1101_HRB156381 , Germany, Active | Mar 29, 2019 | €500M - €1B (As on Dec 31, 2024) | - | |
EVOTEC INTERNATIONAL GMBH CIN: 831855142 , Norway, Active | May 24, 1999 | - | - | |
Evotec International Gmbh CIN: HRB72242 , Germany, Active | Aug 18, 1999 | - | 252 (As on Dec 31, 2020) | |
EVOTEC (US) INC. CIN: 943353740 , United States, Active | Dec 31, 1999 | - | 729 (As on Dec 31, 2024) | - |
Evotec's IPO details
Evotec got listed on Nov 10, 1999.
Click here to take a look at Evotec's IPO in detail
Sign up to download Evotec's company profile
Evotec's funding and investors
Evotec has raised a total funding of $25.1M over 23 rounds. Its first funding round was on Mar 29, 1998. Its latest funding round was a Grant (prize money) round on Jan 08, 2026 for $*****. 1 investor participated in its latest round. Evotec has 24 institutional investors.
Here is the list of recent funding rounds of Evotec:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 08, 2026 | 9322465 | Grant (prize money) | 4455471 | 2279325 | 5601315 | 6836868 |
May 08, 2025 | 5452100 | Grant (prize money) | 8188455 | 1654195 | 2414677 | |
Apr 11, 2025 | 2619452 | Grant (prize money) | 6858001 | 6634270 | 3251210 |
View details of Evotec's funding rounds and investors
Evotec's founders and board of directors
Founder? Claim ProfileEvotec's employee count trend
Evotec has 4,693 employees as of Sep 26. Here is Evotec's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Evotec's Competitors and alternates
Top competitors of Evotec include Euretos, Mechanome Bio and CellCircuit. Here is the list of Top 10 competitors of Evotec, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AI-driven life science company accelerating drug discovery and development | $25.1M | 76/100 | ||
2nd | Euretos 2012, Utrecht (Netherlands), Unfunded | Developer of AI platform for in-silico discovery and validation of targets and biomarkers | - | - | 25/100 |
3rd | Mechanome Bio 2025, Cambridge (United Kingdom), Funding Raised | Developer of artificial intelligence platforms for precision mechanical disease therapeutics | - | 24/100 | |
4th | CellCircuit 2026, San Francisco (United States), Unfunded | Developer of platforms integrating engineered human biology with computational analysis | - | - | 24/100 |
5th | Platinum Discovery 2019, Edinburgh (United Kingdom), Unfunded | Provider of multiomics research and precision medicine services | - | - | 18/100 |
6th | ![]() AmarnaBio Durham (United States), Unfunded | Developer of RNA analysis platforms for diagnostic and therapeutic discovery | - | - | 16/100 |
Looking for more details on Evotec's competitors? Click here to see the top ones
Evotec's Investments and acquisitions
Evotec has made 22 investments in companies including Tubulis Technologies and Aeovian Pharmaceuticals. Evotec has also acquired 11 companies including Central Glass and Central Glass.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 14, 2024 | Investments | 2015 | Munich (Germany) | |
Dec 22, 2023 | Investments | 2012 | San Francisco (United States) | |
Dec 01, 2022 | Investments | 2015 | Oxford (United Kingdom) |
See all investments and acquisitions by Evotec
Reports related to Evotec
Here is the latest report on Evotec's sector:
News related to Evotec
Media has covered Evotec for a total of 67 events in the last 1 year, 24 of them have been about company updates and 12 about people movement.
•
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management BoardPR Newswire•Oct 15, 2026•Evotec
•
•
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical StudiesPR Newswire•Sep 09, 2026•Evotec
•
BioNTech and Bayer: Full Coffers Fuel Takeover AppetiteStockhouse Publishing•Sep 08, 2026•Evotec, Bayer, Gruenenthal Group
•
Evotec and Plectonic Biotech Collaborate on Novel Immunotherapy for Solid TumorsPR Newswire•Sep 02, 2026•Evotec
•
•
Evotec and Odyssey Therapeutics Form R&D Partnership for Autoimmune and Inflammatory DiseasesContract Pharma•Aug 07, 2026•Evotec, Odyssey
•
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial ResultsBusiness Wire•Aug 05, 2026•Niagen Bioscience, Evotec
•
Niagen Bioscience Selects Evotec for Preclinical Development of Oral Small-Molecule CandidateContract Pharma•Aug 04, 2026•Evotec, Niagen Bioscience
•
Evotec chooses Navan to unify travel, payments and expense management globallyBusiness Wire•Jul 23, 2026•Navan, Evotec
Are you a Founder ?
FAQs about Evotec
Explore our recently published companies
- Lacy And Par - Tukwila based, 1984 founded, Unfunded company
- Moeheat - Santa Clarita based, 2008 founded, Public company
- Z-axis Prints - Spokane based, 2010 founded, Unfunded company
- Zen Creative Group - Portland based, 1995 founded, Unfunded company
- Rjo Ventures - North Miami Beach based, 2011 founded, Unfunded company
- Roberts Design - Las Vegas based, 2014 founded, Unfunded company
